Simone M C Spoorenberg, Stefan M T Vestjens, W. Albrich, G. Rijkers
{"title":"所有社区获得性肺炎的成年患者使用糖皮质激素?","authors":"Simone M C Spoorenberg, Stefan M T Vestjens, W. Albrich, G. Rijkers","doi":"10.15172/pneu.2015.6/690","DOIUrl":null,"url":null,"abstract":"Corticosteroid therapy as adjunctive treatment in community-acquired pneumonia (CAP) is a promising but controversial subject. The potentially beneficial effect of corticosteroids is based on the ability of steroids to dampen an excessive inflammatory response that often occurs in patients with CAP. This excessive inflammatory response can cause damage to the lungs and other organs, and is associated with poor outcome.","PeriodicalId":45120,"journal":{"name":"Pneumonia","volume":"6 1","pages":"44 - 47"},"PeriodicalIF":8.5000,"publicationDate":"2015-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.15172/pneu.2015.6/690","citationCount":"0","resultStr":"{\"title\":\"Corticosteroids for all adult patients with community-acquired pneumonia?\",\"authors\":\"Simone M C Spoorenberg, Stefan M T Vestjens, W. Albrich, G. Rijkers\",\"doi\":\"10.15172/pneu.2015.6/690\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Corticosteroid therapy as adjunctive treatment in community-acquired pneumonia (CAP) is a promising but controversial subject. The potentially beneficial effect of corticosteroids is based on the ability of steroids to dampen an excessive inflammatory response that often occurs in patients with CAP. This excessive inflammatory response can cause damage to the lungs and other organs, and is associated with poor outcome.\",\"PeriodicalId\":45120,\"journal\":{\"name\":\"Pneumonia\",\"volume\":\"6 1\",\"pages\":\"44 - 47\"},\"PeriodicalIF\":8.5000,\"publicationDate\":\"2015-08-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.15172/pneu.2015.6/690\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pneumonia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15172/pneu.2015.6/690\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pneumonia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15172/pneu.2015.6/690","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
Corticosteroids for all adult patients with community-acquired pneumonia?
Corticosteroid therapy as adjunctive treatment in community-acquired pneumonia (CAP) is a promising but controversial subject. The potentially beneficial effect of corticosteroids is based on the ability of steroids to dampen an excessive inflammatory response that often occurs in patients with CAP. This excessive inflammatory response can cause damage to the lungs and other organs, and is associated with poor outcome.